Mehmet Fatih Yetkin

Akademik Profiller

1. 1
   Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosisArchives of Rheumatology
   2021
2. 2
   The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?Multiple Sclerosis and Related Disorders
   2021
3. 3
   Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomideNeurological Sciences
   2021
4. 4
   A case of fulminant demyelinating disease associated with golimumab treatmentClinical Neurology and Neurosurgery
   2020
5. 5
   Chemotherapy-induced toxic leukoencephalopathy,Kemoterapi ilişkili toksik lökoensefalopatiTurk Noroloji Dergisi
   2020
6. 6
   Efficacy and tolerability of interferon gamma in treatment of friedreich’s ataxia: Retrospective studyNoropsikiyatri Arsivi
   2020
7. 7
   Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patientsJournal of Neuroimmunology
   2020
8. 8
   Comparison of peripheral blood th17 cells and associated cytokines in fingolimod-receiving and untreated multiple sclerosis patients,Fingolimod alan ve almayan multiple skleroz hastalarının perifierik kanında th17 hücrelerinin karşılaştırılmasıTurkish Journal of Immunology
   2019
9. 9
   Diffusion tensor imaging of the median nerve healing. Preliminary resultsAnnali Italiani di Chirurgia
   2019
10. 10
    Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cellsFrontiers in Immunology
    2019

Yayın listesi ORCID kaydından alındı.